Compare Kymera Therapeutics Inc. Common Stock (KYMR) vs Toronto-Dominion Bank (TD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Kymera Therapeutics Inc. Common Stock vs Toronto-Dominion Bank — how do they compare? Kymera Therapeutics Inc. Common Stock trades at $105.11 (market cap $8.88B), while Toronto-Dominion Bank trades at $118 (market cap $192.46B). The key difference: Toronto-Dominion Bank is far larger — about 21.7× Kymera Therapeutics Inc. Common Stock's market cap, and Toronto-Dominion Bank pays a 2.67% dividend while Kymera Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Kymera Therapeutics Inc. Common Stock for 0 Days and Toronto-Dominion Bank for 85 Days on average.
| KYMR | TD | |
|---|---|---|
Market Cap | $8.88B | $192.46B |
Volume | 1,028,790 | 2,419,463 |
Sector | Health | Financials |
52-Week High | $127.31 | $124.80 |
52-Week Low | $55.80 | $78.72 |
Typical Hold Time | 0 Days | 85 Days |
Enterprise Value | $8.27B | $567.89B |
Dividend Yield | — | 2.67% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
TD stock trades at $117.95, up 1.25% today, with a bearish technical signal but strong fundamental performance. Recent earnings have consistently beaten estimates, with a net income margin of 24.88% and ROE of 13.64%. The company announced a $10 billion share buyback and a $108 billion commitment to Canadian infrastructure, signaling confidence in future growth. Analyst consensus is positive with 53% buy ratings and no sell recommendations.
The outlook is mixed; strong profitability and shareholder returns support upside, but technical indicators and volatile cash flows pose risks. Investors should weigh robust earnings against bearish momentum and macroeconomic uncertainties affecting the banking sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Kymera Therapeutics Inc. Common Stock
Kymera Therapeutics, Inc. is a biopharmaceutical company developing small-molecule medicines based on targeted protein degradation, using its Pegasus platform to direct the body's natural protein-disposal system against disease-causing proteins.
Read more on KYMR →About Toronto-Dominion Bank
Toronto-Dominion is one of Canada's two largest banks and operates three business segments: Canadian retail banking, U.S. retail banking, and wholesale banking. The bank's U.S. operations span from Maine to Florida, with a strong presence in the Northeast. It also has a 13% ownership stake in Charles Schwab.
Read more on TD →
